• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BD1

BARD1 LIFE SCIENCES LIMITED - Charts / Financials

0.98% ! $1.04
Currently unlisted.
Add to My Watchlist

BARD1 Life Sciences Limited is an Australia-based medical diagnostics company. The... BARD1 Life Sciences Limited is an Australia-based medical diagnostics company. The Company is engaged in research, development, and commercialization of non-invasive diagnostic products for the early detection of cancer. The Company’s technologies include BARD1, SubB2, NET and hTERT. BARD1 is a biomarker platform covering various tumor markers including nucleic acids, proteins, and autoantibodies for early cancer diagnosis.SubB2M is a pan-cancer probe for monitoring cancer treatment response and recurrence across a wide range of cancers. NET is designed to capture and purify biomarkers, including acids, cells, and exosomes. hTERT is an antibody-based assay to detect hTERT, a component of telomerase, in cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day chart unavailable
Last update - 16.10pm 08/12/2021 (20 minute delay) ?
Day
Open $1.05   Day High $1.07   Day Low $1.04
Daily Volume 218469
Bids   Sellers
Number Price Volume   Number Price Volume
4 $1.03 33000   1 $1.08 2222

Directors & Senior Management

Prof. Allan William Cripps Non-Executive Independent Director
Mr. Geoffrey Cumming Director
Dr. Greg Rice Chief Scientific Officer
Dr. Irmgard Irminger-Finger Chief Scientific Officer
Dr. Leearne Maree Hinch Chief Executive Officer
Mr. Philip J. Powell Director
Mr. Robert Maxwell Johnston Director

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Dale Gillham: Has crypto lost its magic? Investors rethink 'digital gold' narrative

Bitcoin and the crypto market built its reputation on a simple promise: buy and hold it, and eventually you’ll be rewarded, but right now, that belief is being tested. Following one of its biggest declines in recent years, roughly half of all Bitcoin holders are now sitting on a l...
Australian Oil Company ramping up Surat Basin development Australian Oil Company is ramping up oil and gas production growth at its Surat Basin operations in central Australia.
Lithium will surge again. This explorer has a secret weapon for when it does Prairie Lithium is a company actively differentiating by building through the lithium downturn, rather than waiting for sentiment to return.
From the Wire: Make way for the 'MANGOS' as Wall Street's AI hype comes back to reality On this week’s HotCopper Wire, hosts Isaac McIntyre and Jonathon Davidson took a look at the wobble in Wall Street’s bullish AI hype, how much is really vibes-based over any real fundamental investing, and whether, above all that, the bumper CY26 IPO listings just ...
Listen: HotCopper Wire Podcast #050 – Droning on (and on and on…) In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson crack into why Australian traders are rotating into defensive stocks so heavily (who can blame them, really) and the big AI story in the States.Hear from all the ASX-listed companies that were at the RIU R...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.